Fr. 57.50

SIDNONES: CHEMICAL AND ANTITUMOR PROPERTIES - A narrative review. DE

English · Paperback / Softback

Shipping usually within 1 to 2 weeks (title will be printed to order)

Description

Read more

Mesoionic compounds are synthetic substances that belong to the class of heterocyclic betaines. Among this class, the sidnones stand out. The sydnones were first prepared by Earl and Mackney at the University of Sydney in 1935 and this gave rise to their name: sydnone. They have structures, chemical properties, synthetic utility and biological activities that are considered relevant. One of these characteristics is their possible anti-cancer effect. Cancer is one of the main causes of death and every year more people are affected by the disease. Current treatments have low efficacy and many side effects, which is why there is a great desire for new, more effective drugs to treat this disease. For this reason, the aim of this work was to provide a narrative review to analyze the potential of siddnones for future use in cancer therapy, as well as detailing their chemical and unique properties.

About the author










Mariana Borges Barreto Bezerra poluchila stepen' bakalawra po promyshlennoj himii w Federal'nom sel'skom uniwersitete Rio-de-Zhanejro.Ana Paula Pereira da Silwa - docent kafedry biohimii w Federal'nom sel'skom uniwersitete Rio-de-Zhanejro.

Product details

Authors Mariana Borges Barreto Bezerra, Ana Paula Pereira Da Silva
Publisher Our Knowledge Publishing
 
Languages English
Product format Paperback / Softback
Released 21.08.2024
 
EAN 9786207972661
ISBN 9786207972661
No. of pages 56
Subject Natural sciences, medicine, IT, technology > Biology > Biochemistry, biophysics

Customer reviews

No reviews have been written for this item yet. Write the first review and be helpful to other users when they decide on a purchase.

Write a review

Thumbs up or thumbs down? Write your own review.

For messages to CeDe.ch please use the contact form.

The input fields marked * are obligatory

By submitting this form you agree to our data privacy statement.